News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
CSL to Build $235 Million Manufacturing Facility
July 20, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
in-pharmatechnologist -- Australian vaccine maker CSL says new $235m plant will advance development of its portfolio of biotech cancer drugs, anti-infectives and plasma products.
Twitter
LinkedIn
Facebook
Email
Print
Real estate
Asia
Australia
MORE ON THIS TOPIC
Layoffs
Passage cuts 75% of workforce after FDA trial design request
May 4, 2026
·
1 min read
·
Angela Gabriel
Manufacturing
PCI adds US sterile fill/finish capabilities through $1B global expansion drive
May 4, 2026
·
2 min read
·
Nick Paul Taylor
Mergers & acquisitions
UCB captures Candid in $2.2B autoimmune deal as pharma’s M&A train chugs along
May 4, 2026
·
2 min read
·
Tristan Manalac
Obesity
Obesity ends oncology’s long reign as top contributor to biopharma pipeline value
May 4, 2026
·
2 min read
·
Nick Paul Taylor
